COR Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Cencora Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 224.74 USD -1.95%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast COR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COR is 263.96 USD with a low forecast of 231.29 USD and a high forecast of 294 USD.

COR Lowest Forecast

Wall Street Target

COR Average Forecast

Wall Street Target

COR Highest Forecast

Wall Street Target

3% Upside

17% Upside

31% Upside

The latest public price target was made on Apr 5, 2024 by David Rodgers from Robert W. Baird , who expects COR stock to rise by 22% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
David Rodgers Robert W. Baird	275 USD Upside 22%	4 weeks ago Apr 5, 2024	Cencora Inc (COR) PT Raised to $275 at Baird, 'expect continued strong execution' StreetInsider
David Toung Argus Research	270 USD Upside 20%	4 weeks ago Apr 4, 2024	Cencora Inc (COR) PT Raised to $270 at Argus StreetInsider
Ann Hynes Mizuho Securities	174 USD Downside 23%	1 year ago May 3, 2023	Healthcare Solutions Trends And M&A Prospects: AmerisourceBergen Gets A Price Target Hike Amid Upside Scenarios Benzinga

Price Target	275 USD
Upside/Downside	22%

Price Target	270 USD
Upside/Downside	20%

Price Target	174 USD
Upside/Downside	23%

Haemato AG

59% Upside

As One Corp

45% Upside

Neuca SA

0% Upside

Charmacy Pharmaceutical Co Ltd

24% Downside

Haemato AG

59% Upside

As One Corp

45% Upside

Neuca SA

0% Upside

Charmacy Pharmaceutical Co Ltd

24% Downside

Mckesson Corp

11% Upside

Zhejiang Zhenyuan Share Co Ltd

98% Upside

Qingdao Baheal Medical Inc

61% Upside

Excelsior Medical Co Ltd

17% Downside

Revenue
Forecast

For the last 8 years the compound annual growth rate for Cencora Inc's revenue is 9%. The projected CAGR for the next 3 years is 8%.

9%

8%

-1%

What are analyst estimates?

Operating Income
Forecast

For the last 8 years the compound annual growth rate for Cencora Inc's operating income is 26%. The projected CAGR for the next 3 years is 18%.

26%

18%

-13%

What are analyst estimates?

Net Income
Forecast

The compound annual growth rate of Cencora Inc's net income for the next 3 years is 23%.

N/A

23%

-23%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for COR is 263.96 USD with a low forecast of 231.29 USD and a high forecast of 294 USD.

For the last 8 years the compound annual growth rate for Cencora Inc's revenue is 9%. The projected CAGR for the next 3 years is 8%.

For the last 8 years the compound annual growth rate for Cencora Inc's operating income is 26%. The projected CAGR for the next 3 years is 18%.

The compound annual growth rate of Cencora Inc's net income for the next 3 years is 23%.

Join more than 133,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.